 
        Dronabinol similar in safety and efficacy as diphenhydramine for neuropathic pain relief
 
                                                    Dronabinol similar in safety and efficacy as diphenhydramine for neuropathic pain relief
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study
Am J Phys Med Rehabil. 2010 Oct;89(10):840-8. doi: 10.1097/PHM.0b013e3181f1c4ecSynopsis
9 patients with spinal cord injury and experiencing chronic neuropathic pain were randomly assigned to treatment with either dronabinol or diphenhydramine for 56 days, and then crossed over to the other medication for 56 days after a 7-day washout period. Patient-reported pain intensity and the incidence of side effects were assessed at the beginning and the end of each medication phase. The resul...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.